AusPAR: Nuvaxovid

Australian Public Assessment Report

AusPAR

AusPAR: NUVAXOVID [PDF, 766.2 KB]

AusPAR: NUVAXOVID [Word, 1.79 MB]

Attachment Product information for NUVAXOVID [PDF, 399 KB]

Attachment Product information for NUVAXOVID [Word, 79.75 KB]

Device/Product Name

NUVAXOVID

Active ingredients

SARS-CoV-2 rS [NVX-CoV2373]) COVID-19 vaccine

AusPAR Date

31 May 2024

Published

12 June 2024

Submission Number

PM-2023-00909-1-2

Submission Type

Major variation (new dosage regimen)

Decision

Approved